The first biologic treatment for psoriasis, Amevive (Am-uh-veev), is now approved and on the market

The first biologic treatment for psoriasis, Amevive (Am-uh-veev), is now approved and on the market.

Amevive (alefacept) is an immunosuppressant. It inhibits the T-cells that contribute to psoriasis.

It's given IM once weekly for 12 weeks...followed by a 12-week break. Some patients will be taught to self-inject IM at home.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote